Wound exudate collection method for chronic ulcers

Wound Repair and Regeneration

Volumn 20, Issue 3, 2012, Pages 294-303

  Kroeze, Kim L ^a   Vink, Liselot ^a   De Boer, Edith M ^a   Scheper, Rik J ^a   Van Montfrans, Catherine ^a   Gibbs, Susan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; BIOLOGICAL MARKER; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEBRIDEMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEG ULCER; MALE; PRIORITY JOURNAL; WOUND FLUID; WOUND HEALING; CELL CULTURE; CHRONIC DISEASE; EXUDATE; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PREDICTIVE VALUE; VARICOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELLS, CULTURED; CHEMOKINE CCL20; CHEMOKINE CXCL1; CHRONIC DISEASE; DEBRIDEMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; VARICOSE ULCER; WOUND HEALING;

EID: 84860606311     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00789.x     Document Type: Article

References (42)

1. Margolis DJ, Bilker W, Santanna J, Baumgarten M,. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002; 46: 381-386. (Pubitemid 34225402)
2. Maessen-Visch MB, Zelm van RT, Bartelink MEL, de Boer EM, Daniels-Marckmann A, van Gent WB, van Gerwen HJL, Klokman EW, van Leen MWF, Munte K, van Praag MCG, Qcak ABWM, Veraart JCJM, Wittens CHA, de Zeeuw R,. Ulcus cruris venosum (Dutch). 2005. (accessed January 5, 2011).
3. Gohel MS, Taylor M, Earnshaw JJ, Heather BP, Poskitt KR, Whyman MR,. Risk factors for delayed healing and recurrence of chronic venous leg ulcers-an analysis of 1324 legs. Eur J Vasc Endovasc Surg 2005; 29: 74-77. (Pubitemid 39618995)
4. Gelfand JM, Hoffstad O, Margolis DJ,. Surrogate endpoints for the treatment of venous leg ulcers. J Invest Dermatol 2002; 119: 1420-1425. (Pubitemid 36005630)
5. Gillitzer R, Goebeler M,. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-521. (Pubitemid 32294835)
6. Werner S, Grose R,. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870. (Pubitemid 36828927)
7. Harding KG, Morris HL, Patel GK,. Science, medicine and the future: healing chronic wounds. BMJ 2002; 324: 160-163. (Pubitemid 34084511)
8. Cowin AJ, Hatzirodos N, Rigden J, Fitridge R, Belford DA,. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid. Wound Rep Reg 2006; 14: 421-426. (Pubitemid 44266598)
9. Gohel MS, Windhaber RA, Tarlton JF, Whyman MR, Poskitt KR,. The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J Vasc Surg 2008; 48: 1272-1277.
10. Wallace HJ, Stacey MC,. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol 1998; 110: 292-296. (Pubitemid 28144608)
11. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC,. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Rep Reg 2000; 8: 13-25. (Pubitemid 30140796)
12. Pukstad BS, Ryan L, Flo TH, Stenvik J, Moseley R, Harding K, Thomas DW, Espevik T,. Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers. J Dermatol Sci 2010; 59: 115-122.
13. Fivenson DP, Faria DT, Nickoloff BJ, Poverini PJ, Kunkel S, Burdick M, Strieter RM,. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Rep Reg 1997; 5: 310-322. (Pubitemid 127689592)
14. Yager DR, Kulina RA, Gilman LA,. Wound fluids: a window into the wound environment? Int J Low Extrem Wounds 2007; 6: 262-272. (Pubitemid 350131921)
15. Stechmiller JK, Kilpadi DV, Childress B, Schultz GS,. Effect of Vacuum-Assisted Closure Therapy on the expression of cytokines and proteases in wound fluid of adults with pressure ulcers. Wound Rep Reg 2006; 14: 371-374. (Pubitemid 43979269)
16. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK,. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996; 107: 743-748. (Pubitemid 26371092)
17. Trengove NJ, Langton SR, Stacey MC,. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Rep Reg 1996; 4: 234-239. (Pubitemid 126674092)
18. Schmidtchen A,. Chronic ulcers: a method for sampling and analysis of wound fluid. Acta Derm Venereol 1999; 79: 291-295. (Pubitemid 29302058)
19. US Department of Health and Human Services Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), and Center for Devices and Radiological Health (CDRH). Guidance for industry; Chronic cutaneous ulcers and burn wounds-developing products for treatment. 1-6- 2006. Online source. Available at (accessed January 5, 2011).
20. Kroeze KL, Jurgens WJ, Doulabi BZ, van, Milligen FJ, Scheper RJ, Gibbs S,. Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES. J Invest Dermatol 2009; 129: 1569-1581.
21. Gibbs S, van den Hoogenband HM, Kirtschig G, Richters CD, Spiekstra SW, Breetveld M, Scheper RJ, de, Boer EM,. Autologous full-thickness skin substitute for healing chronic wounds. Br J Dermatol 2006; 155: 267-274. (Pubitemid 44050558)
22. Spiekstra SW, Breetveld M, Rustemeyer T, Scheper RJ, Gibbs S,. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Rep Reg 2007; 15: 708-717. (Pubitemid 47493892)
23. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G,. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Reg 1999; 7: 442-452. (Pubitemid 30027566)
24. Buchstein N, Hoffmann D, Smola H, Lang S, Paulsson M, Niemann C, Krieg T, Eming SA,. Alternative proteolytic processing of hepatocyte growth factor during wound repair. Am J Pathol 2009; 174: 2116-2128.
25. Mast BA, Schultz GS,. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Rep Reg 1996; 4: 411-420. (Pubitemid 126670858)
26. Maish GO III, Shumate ML, Ehrlich HP, Vary TC, Cooney RN,. Interleukin-1 receptor antagonist attenuates tumor necrosis factor-induced alterations in wound breaking strength. J Trauma 1999; 47: 533-537. (Pubitemid 29444393)
27. Wall IB, Moseley R, Baird DM, Kipling D, Giles P, Laffafian I, Price PE, Thomas DW, Stephens P,. Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol 2008; 128: 2526-2540.
28. Raffetto JDR, Mendez MV, Marien BJ, Byers HR, Phillips TJ, Park HY, Menzoian JO,. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid. J Vasc Surg 2001; 33: 1233-1241.
29. Mendez MV, Raffetto JD, Phillips T, Nenzoian JO, Park HY,. The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: a potential mechanism for senescence in venous ulcers. J Vasc Surg 1999; 30: 734-743. (Pubitemid 29487567)
30. Seah CC, Phillips TJ, Howard CE, Ponova IP, Hayes CM, Asandra AS, Park HY,. Chronic wound fluid suppresses proliferation of dermal fibroblasts through ras-mediated signaling pathway. J Invest Dermatol 2005; 124: 466-474. (Pubitemid 40175897)
31. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M,. Growth factors and cytokines in wound healing. Wound Rep Reg 2008; 16: 585-601.
32. Marston WA, Hanft J, Norwood P, Pollak R,. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003; 26: 1701-1705. (Pubitemid 36929107)
33. Falanga V, Sabolinski M,. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Rep Reg 1999; 7: 201-207. (Pubitemid 29439206)
34. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, Marston WA,. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg 2009; 49: 1013-1020.
35. Cardinal M, Eisenbud DE, Armstrong DG, Zelen C, Driver V, Attinger C, Phillips T, Harding K,. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Rep Reg 2009; 17: 306-311.
36. Cornell RS, Meyr AJ, Steinberg JS, Attinger CE,. Debridement of the noninfected wound. J Am Podiatr Med Assoc 2010; 100: 353-359.
37. Grinnell F, Ho CH, Wysocki A,. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 1992; 98: 410-416.
38. Yager DR, Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Kelman Cohen I,. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Reg 1997; 5: 23-32. (Pubitemid 127686717)
39. Gill SE, Parks WC,. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008; 40: 1334-1347.
40. Schreml S, Szeimies RM, Prantl L, Landthaler M, Babilas P,. Wound healing in the 21st century. J Am Acad Dermatol 2010; 63: 866-881.
41. Eming SA, Krieg T, Davidson JM,. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007; 127: 514-525.
42. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW,. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83: 113-118. (Pubitemid 24016522)